Healios K.K.
Notice Regarding Change of Shipment Timing for Initial Order of Conditioned Media Products to JENECELL
Shipment timing for the initial order of conditioned media products has been delayed to October 2026. Revenue will be recognized upon completion of shipment; therefore, recognition is expected to shift from the originally anticipated Q3 of the fiscal year ending December 2026 to Q4, and revenue will be recorded at the time of shipment completion. There are no manufacturing issues; the delay is due to transportation procedure delays. Any further disclosures will be announced promptly.
Key Figures
- Amount equivalent of initial order: 144 million yen
- Delayed shipment destination timing: October 2026
- Revenue recognition timing: Upon completion of shipment
AI要約
Overview
Shipment timing for the initial order under the conditioned media supply agreement with JENECELL, equivalent to 144 million yen, has been delayed to October 2026 due to logistics procedure delays. There are no issues with manufacturing, and shipment preparations are being advanced through close coordination. Revenue will be recognized upon completion of shipment, and the originally anticipated recognition timing is expected to move from Q3 to Q4 of the fiscal year ending December 2026.
Background and Outlook
The cause of the delay is delays in transportation procedures for overseas shipment, and it is not related to product quality or manufacturing capacity. We will provide a further notice when shipment is completed, and if additional disclosures become necessary we will promptly inform stakeholders. JENECELL conducts business centered on stem cell-conditioned media, and both companies will work closely to complete shipment as quickly as possible.
Healios K.K.
Company overview · Stock price · Financial data · All IR
